Clinical Trial

A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this trial is to learn if a resilience intervention can lead to improvements in lymphoma survivors' quality of life.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2029-01 -> 2029-09 2026-07-07
minor Completion pushed: 2030-01 -> 2030-08 2026-07-07
Trial Details
NCT Number NCT07013435
Lead Sponsor Massachusetts General Hospital
Conditions Lymphoma
Enrollment 254 participants
Start Date 2026-08-31
Primary Completion 2029-09 (estimated)
Study Completion 2030-08 (estimated)
Updated on ClinicalTrials.gov 2026-08-11